New dialysis fluid aims to cut sugar side effects
Disease control
Recruiting now
This phase 3 trial tests XyloCore, a dialysis solution with less glucose and added xylitol and L-carnitine, in 170 adults with end-stage kidney disease on continuous ambulatory peritoneal dialysis. The goal is to see if it can maintain dialysis effectiveness while improving metab…
Phase: PHASE3 • Sponsor: Iperboreal Pharma Srl • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC